Cardiovascular outcomes after a change in prescription policy for clopidogrel

Keyphrases

• Cardiovascular Outcomes 100%
• Clopidogrel 100%
• Prescription Rule 100%
• Prior Authorization 66%
• Percutaneous Coronary Intervention 50%
• Timely Access 33%
• Acute Myocardial Infarction 33%
• Population-based 16%
• Bleeding 16%
• Series Analysis 16%
• Death Rate 16%
• Myocardial Infarction 16%
• Coronary Artery Bypass Grafting 16%
• Population Impact 16%
• Hospital Discharge 16%
• Patient Outcomes 16%
• Median Time 16%
• Adverse Effects 16%
• Thrombosis 16%
• Major Bleeding 16%
• Ontario Canada 16%
• Standard of Care 16%
• Aspirin 16%
• Provincial Government 16%
• Authorization Policy 16%
• Pharmacy Benefits 16%
• Coronary Stenting 16%
• Recurrent Myocardial Infarction 16%
• Use Period 16%
• Reimbursement Mechanisms 16%
• Coronary Stent 16%
• Acute Disease 16%
• Drug Reimbursement 16%

Nursing and Health Professions

• Clopidogrel 100%
• Acute Heart Infarction 50%
• Percutaneous Coronary Intervention 50%
• Bleeding 33%
• Stent 33%
• Hospital Discharge 16%
• Heart Infarction 16%
• Adverse Event 16%
• Treatment Outcome 16%
• Drug Therapy 16%
• Health Care Quality 16%
• Coronary Artery Bypass Graft 16%
• Reimbursement 16%
• Time Series Analysis 16%
• Coronary Stenting 16%
• Coronary Stent 16%
• Thrombosis 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Clopidogrel 100%
• Acute Heart Infarction 50%
• Bleeding 33%
• Adverse Event 16%
• Heart Infarction 16%
• Thrombosis 16%
• Acetylsalicylic Acid 16%